|
Copyright 2008-2015 Ennovance Capital LLC. All Rights Reserved. |
|
Frequently Asked Questions
Q: How is Ennovance Capital differentiated from other private equity firms? A: Ennovance stands out among private equity firms in several ways:
Industry Focused: Ennovance makes direct investments primarily within the broader chemical industry (i.e., chemical and chemical-related); this focus enables us to optimize value creation as we are more capable of creating synergies and discovering potential for growth within the industry. Members of the Ennovance team have spent their careers learning the chemical industry while also having executed transactions valued in the billions of dollars within the chemical industry. This industry-focused expertise and experience can be utilized for the benefit of portfolio companies to drive growth and substantial value creation. Please see the Investment Experience portion of the website for further details.
Industry Experience: The Ennovance team has extensive executive experience within the chemical industry; the senior management team has over 130 years of relevant experience and as a whole, the team has members with highly successful past careers as executives in over 15 of the largest multinational chemical companies. This accumulated experience allows Ennovance to not only find deals directly and efficiently, but also facilitates the implementation of operational improvements and strategic growth initiatives within portfolio companies. In addition, Ennovance leverages its extensive global network of high-value relationships to help create value at portfolio companies.
Real Value: As a firm, our primary focus is to add value through the implementation of operational improvements and strategic growth initiatives complemented by carefully selected strategic acquisitions to create the foundation for long-term, sustainable growth. While most private equity firms will hold companies for 3-5 years and attempt to profit through a “quick flip” relying primarily on financial engineering, our target hold period for our portfolio companies is 5-10 years due to our commitment to creating real, sustainable, long-term value, which our experience has taught us cannot be achieved overnight.
Q: How broadly does Ennovance define ‘broader chemical’? A: For the most part, Ennovance focuses on the basic and specialty chemical, healthcare (as it relates to chemistry), allied product, and specialty material sectors, which encompasses a wide array of products and still enables us to invest in a broad range of companies. For example, we could invest in a company that produces hair-care products just as easily as we could in a company that manufactures plastics. For more details about the chemical industry and the various sectors it entails, please visit the Industry Focus section on the Home Page.
Q: Does my company meet Ennovance’s investment criteria? A: Your company will meet our standards if it falls under our definition of broader chemical (see above) and meets the investment criteria detailed on our Strategy page. However, we maintain a level of flexibility with respect to the type of investment opportunities we will consider. So, please contact us at bd@ennovance.com if you wish to discuss a potential investment in your company.
Q: How can I introduce an investment opportunity to Ennovance? A: If you are looking to sell your business or for growth capital, know of a business seeking a buyer, or are looking for a partner for a joint investment, please do not hesitate to contact us at bd@ennovance.com to discuss and provide the appropriate details.
Q: How closely does Ennovance get involved with its portfolio companies? A: Since one of our greatest strengths is our team’s deep operating expertise within the broader chemical industry, we work closely with the existing management teams of our portfolio companies to identify growth prospects in order to build sustainable, long-term value.
Q: What types of investment opportunities is Ennovance willing to consider? A: We look to make buyout, recapitalization, turnaround, and growth equity investments in well-established companies with proven, commercialized technologies that demonstrate solid revenue streams and good opportunities for growth. We do not make investments in start-ups or companies in early stages of development. Ideally, our target investments are cash flow positive, but exceptions can be made in cases where revenue is sufficient or where a turnaround may be possible.
Q: What is Ennovance’s target holding period? A: We target holding periods for our portfolio companies of anywhere between 5-10 years; although this is longer than the holding periods of traditional private equity firms, we believe a longer holding period is in accordance with ensuring the creation of long-term, sustainable growth.
Q: Does Ennovance have a geographical preference for investments? A: We prefer to invest in companies in the US, but have the flexibility to invest globally given the attractiveness of the opportunity.
Q: Where does Ennovance invest along the chemical industry value chain? A: We make investments across the value chain, which includes companies whose business models focus on manufacturing, formulation, application, compounding, distribution, and services.
|
|
Home |
|
Strategy |
|
Our Team |
|
Experience |
|
Philanthropy |
|
News Center |